fosbretabulin: Clinical Trials

7 trials of fosbretabulin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 3 terminated. 7 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 17Completed 4, Terminated 3
Phase 23Terminated 2, Completed 1

Follow fosbretabulin: new trials by email Literature Review of fosbretabulin trials Research Report on fosbretabulin

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fosbretabulin With Everolimus in Neuroendocrine Tumors With Progression
everolimus, fosbretabulin - Neuroendocrine Tumors, Everolimus
Phase 1TerminatedLowell Anthony, MD172017-03-062019-08-08
PAZOFOS: Phase Ib and Phase II Trial of Pazopanib +/- Fosbretabulin in Advanced Recurrent Ovarian Cancer
Pazopanib, Fosbretabulin - Ovarian Neoplasms, Neoplasms, Ovarian
Phase 1 / Phase 2TerminatedThe Christie NHS Foundation Trust212014-09-012021-05-17
Safety Study of Increasing Doses of Combretastatin in Combination With Bevacizumab (Avastin) in Patients With Advanced Solid Tumors
Combretastatin A4 Phosphate (CA4P), Bevacizumab (Avastin) - Tumors
Phase 1CompletedMateon Therapeutics202006-09-012011-10-31
Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid Cancer
filgrastim, pegfilgrastim, cisplatin - Head and Neck Cancer
Phase 1 / Phase 2TerminatedCase Comprehensive Cancer Center42003-11-012010-06-11
Combretastatin A4 Phosphate in Patients With Neovascular Age-Related Macular Degeneration
Combretastatin A-4 phosphate, Combretastatin A-4 Phosphate - Combretastatin A4 Phosphate, Age-related Macular Degeneration
Phase 1 / Phase 2CompletedJohns Hopkins University82003-05-012017-12-06
Combretastatin A4 Phosphate in Treating Patients With Advanced Solid Tumors
fosbretabulin disodium - Unspecified Adult Solid Tumor, Protocol Specific
Phase 1CompletedCase Comprehensive Cancer Center251998-09-012014-01-07
Chemotherapy in Treating Patients With Solid Tumors
fosbretabulin disodium - Unspecified Adult Solid Tumor, Protocol Specific
Phase 1CompletedUniversity of Glasgow351998-07-012013-12-19

Conditions studied

Choroidal Neovascularization (1)  ·  Head and Neck Neoplasms (1)  ·  Macular Degeneration (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)  ·  Neuroendocrine Tumors (1)  ·  Ovarian Neoplasms (1)  ·  Thyroid Carcinoma, Anaplastic (1)

Sponsors

Case Comprehensive Cancer Center (2)  ·  Johns Hopkins University (1)  ·  Lowell Anthony, MD (1)  ·  Mateon Therapeutics (1)  ·  The Christie NHS Foundation Trust (1)  ·  University of Glasgow (1)

Countries

United States (4)  ·  United Kingdom (3)

Top investigators

Gordon J.S. Rustin, MD (1)  ·  Gordon Jayson (1)  ·  Gordon Rustin (1)  ·  Hillori Connors, MS (1)  ·  Lowell Anthony, MD (1)  ·  Panayiotis Savvides, MD (1)  ·  Paul Nathan, MD (1)  ·  Peter Harris, MD (1)  ·  Quan D Nguyen, MD, MSc (1)  ·  Scot C. Remick, MD (1)

Results publications

PMID 12807934, PMID 23316779, PMID 31932108, PMID 37816266

NIH funding

P30CA043703 (1)